After a period of weakness, biotech stocks are on the upswing, experts say. But bear in mind: Putting your money into ...

The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic. Click here for ...

The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Europe’s biotech sector drives growth, resilience and strategic autonomy, but market weakness and fragmented regulation are ...

Shares in diagnostic play Nexsen have traded as much as 47% higher after debuting on the ASX today, following an $8 million ...

Anbio Biotechnology is a medical device firm develops in-vitro diagnostics, with stock volatility & thin public float. Read ...

Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

Born in Melbourne and fuelled by local innovation, Salvarity positions itself as skincare ‘backed by bees, biotech and ...

How does biosolutions specialist Novonesis help startups in the biomanufacturing space cross the valley of death?

The biotech and pharma Industries are growing healthcare solutions for the future. These locations support the industry's ...

National security, the blue economy, support for startups and digital jobs are the focus of the four awardees selected from ...